Ptc therapeutics, inc. (PTCT)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Dec'12
Assets
Current assets:
Cash and cash equivalents

123,287

288,028

523,577

136,094

201,144

169,498

206,913

223,788

97,675

111,792

141,838

133,011

54,106

58,321

50,286

35,658

40,165

58,022

140,712

29,220

36,825

49,748

52,873

21,172

115,855

15,414

24,044

154,095

2,725

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

-

-

-

-

-

169,498

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

472,572

398,535

185,072

227,447

206,018

58,088

42,491

72,318

80,595

79,454

27,472

48,058

148,471

173,345

198,052

237,235

258,547

280,903

230,809

225,999

243,642

265,493

156,516

205,687

130,730

127,053

133,182

11,582

-

Trade receivables, net

52,623

55,538

60,383

77,104

46,350

67,907

42,197

59,383

45,611

40,394

38,744

33,767

32,173

24,929

27,409

19,765

22,618

11,094

8,016

5,114

3,178

4,445

-

858

838

958

783

870

1,013

Inventory, Net

19,133

19,285

17,107

16,897

16,219

16,117

13,660

13,852

12,355

10,754

7,792

6,912

1,354

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

24,307

17,898

20,723

17,424

9,348

9,247

8,020

6,305

5,760

6,669

5,413

5,224

4,623

4,691

4,860

4,776

5,104

5,930

4,627

4,241

6,116

3,885

2,831

2,597

1,957

1,599

2,126

1,609

855

Receivables, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,296

-

-

-

-

-

-

Total current assets

691,922

779,284

806,862

474,966

479,079

320,857

313,281

375,646

241,996

249,063

221,259

226,972

240,727

261,286

280,607

297,434

326,434

355,949

384,164

264,574

289,761

323,571

213,516

230,314

249,380

145,024

160,137

168,158

4,595

Fixed assets, net

26,169

21,549

18,484

15,391

14,540

12,694

8,805

8,217

8,302

8,376

6,882

6,839

7,059

7,429

7,059

7,601

8,426

8,974

8,799

9,017

9,408

9,159

6,193

6,417

6,328

6,730

6,942

7,153

8,280

Intangible assets, net

705,294

710,500

702,910

702,729

694,955

701,031

604,612

126,290

127,565

132,993

138,422

148,138

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

82,300

82,341

82,300

82,300

82,341

82,341

100,309

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits and other assets

39,866

30,108

30,889

16,145

12,996

2,299

1,620

1,620

1,548

1,221

1,157

1,129

859

630

511

528

372

358

3,137

231

351

489

1,086

827

132

149

163

156

197

Total assets

1,545,592

1,623,782

1,641,486

1,291,572

1,283,911

1,119,222

1,028,627

511,773

379,411

391,653

367,720

383,078

248,645

269,345

288,177

305,563

335,232

365,281

396,100

273,822

299,520

333,219

220,795

237,558

255,840

151,903

167,244

175,468

13,072

Liabilities and stockholders’ equity
Current liabilities:
Accounts Payable and Accrued Liabilities, Current

145,386

159,276

128,150

122,375

98,450

128,199

102,788

82,534

71,437

76,446

64,054

63,996

45,153

48,759

47,759

42,183

43,493

45,247

31,695

23,082

23,532

29,121

16,493

11,341

8,735

12,207

10,205

10,058

7,023

Current portion of long-term debt

20,000

20,000

20,000

20,000

16,667

11,667

6,667

1,666

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

49

84

2,746

4,444

Deferred revenue

8,638

8,242

8,810

8,005

5,497

3,716

2,004

0

0

3,937

6,122

2,602

-

0

910

726

396

139

-

-

373

3,354

769

242

492

878

3,631

6,983

16,690

Other current liabilities

3,644

8,339

6,840

4,179

3,132

3,814

3,463

2,274

1,279

1,665

1,723

1,387

265

865

257

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred consideration payable

40,000

40,000

19,700

19,400

19,300

19,400

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

217,668

235,857

183,500

173,959

143,046

166,796

114,922

86,474

72,716

82,048

71,899

67,985

45,418

49,624

48,926

42,909

43,889

45,386

31,695

23,082

23,905

32,475

17,262

11,583

9,239

13,134

13,921

19,788

28,158

Deferred revenue- long term

1,768

3,415

5,496

7,797

8,853

9,722

11,156

10,540

9,300

7,954

6,579

3,828

2,194

1,587

-

-

-

0

-

-

-

-

-

-

-

-

-

241

741

Long-term debt

294,574

293,859

293,149

135,683

138,468

141,347

144,258

147,204

146,878

144,971

143,091

141,242

99,895

98,216

96,559

94,936

93,366

91,848

93,198

-

-

-

-

-

-

-

-

-

438

Contingent consideration payable

357,200

356,300

344,900

336,200

330,900

310,240

218,700

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

130,862

130,862

122,032

122,032

122,032

122,032

115,200

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred consideration payable

-

-

19,300

18,800

18,900

18,300

38,200

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

14,786

9,159

9,455

8,416

8,770

58

101

153

209

243

269

292

311

335

2,515

2,094

1,976

2,046

2,056

2,159

2,295

2,277

2,237

2,219

2,259

2,227

2,290

2,518

2,549

Total liabilities

1,016,858

1,029,452

977,832

802,887

770,969

768,495

642,537

244,371

229,103

235,216

221,838

213,347

147,818

149,762

148,000

139,939

139,231

139,280

126,949

25,241

26,200

34,752

19,499

13,802

11,498

15,361

16,211

22,548

31,889

Commitments and contingencies (Note 13)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Stockholders’ equity:
Preferred stock, $0.001 par value. Undesignated 5,000,000 shares; issued and outstanding 0 shares at June 30, 2014 and December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

Common stock, $0.001 par value. Authorized 125,000,000 shares; issued and outstanding 62,758,520 shares at March 31, 2020. Authorized 125,000,000 shares; issued and outstanding 61,935,870 shares at December 31, 2019.

62

62

61

58

58

51

51

47

42

42

41

41

34

34

34

34

34

34

34

34

33

33

30

30

30

24

24

24

0

Additional paid-in capital

1,834,061

1,795,351

1,775,799

1,539,530

1,523,115

1,288,137

1,275,004

1,105,124

975,418

966,534

958,206

949,331

865,834

856,142

847,700

837,850

829,114

820,165

812,294

747,869

734,489

721,722

596,617

591,636

587,128

465,246

461,960

459,391

177,583

Accumulated other comprehensive income

-1,985

-10,584

616

1,922

805

1,462

1,628

1,855

4,953

3,969

3,013

1,999

-876

-1,485

756

885

1,084

-1,200

-1,127

-495

-736

-737

-69

90

80

70

-40

-0

-

Retained Earnings (Accumulated Deficit)

-1,303,400

-1,190,499

-1,112,800

-1,052,800

-1,011,000

-938,923

-890,593

-839,624

-830,105

-814,108

-815,378

-781,640

-764,165

-735,108

-708,313

-673,145

-634,231

-592,998

-542,050

-498,827

-460,466

-422,551

-395,282

-368,000

-342,896

-328,798

-310,912

-306,495

-277,224

Stockholders' Equity Attributable to Parent

528,734

594,330

663,654

488,685

512,942

350,727

386,090

267,402

150,308

156,437

145,882

169,731

100,827

119,583

140,177

165,624

196,001

226,001

269,151

248,581

273,320

298,467

201,296

223,756

244,342

136,542

151,032

152,919

-99,640

Total liabilities and stockholders’ equity

1,545,592

1,623,782

1,641,486

1,291,572

1,283,911

1,119,222

1,028,627

511,773

379,411

391,653

367,720

383,078

248,645

269,345

288,177

305,563

335,232

365,281

396,100

273,822

299,520

333,219

220,795

237,558

255,840

151,903

167,244

175,468

13,072